Cargando…

Substituted Aminoacetamides as Novel Leads for Malaria Treatment

Herein we describe the optimization of a phenotypic hit against Plasmodium falciparum based on an aminoacetamide scaffold. This led to N‐(3‐chloro‐4‐fluorophenyl)‐2‐methyl‐2‐{[4‐methyl‐3‐(morpholinosulfonyl)phenyl]amino}propanamide (compound 28) with low‐nanomolar activity against the intraerythrocy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Norcross, Neil R., Wilson, Caroline, Baragaña, Beatriz, Hallyburton, Irene, Osuna‐Cabello, Maria, Norval, Suzanne, Riley, Jennifer, Fletcher, Daniel, Sinden, Robert, Delves, Michael, Ruecker, Andrea, Duffy, Sandra, Meister, Stephan, Antonova‐Koch, Yevgeniya, Crespo, Benigno, de Cózar, Cristina, Sanz, Laura M., Gamo, Francisco Javier, Avery, Vicky M., Frearson, Julie A., Gray, David W., Fairlamb, Alan H., Winzeler, Elizabeth A., Waterson, David, Campbell, Simon F., Willis, Paul A., Read, Kevin D., Gilbert, Ian H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Full Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899483/ https://www.ncbi.nlm.nih.gov/pubmed/31188540 http://dx.doi.org/10.1002/cmdc.201900329

Ejemplares similares

Discovery of a Quinoline-4-carboxamide Derivative with a Novel Mechanism of Action, Multistage Antimalarial Activity, and Potent in Vivo Efficacy
por: Baragaña, Beatriz, et al.
Publicado: (2016)

Trisubstituted Pyrimidines as Efficacious and Fast-Acting Antimalarials
por: Norcross, Neil R., et al.
Publicado: (2016)

Screening a protein kinase inhibitor library against Plasmodium falciparum
por: Hallyburton, Irene, et al.
Publicado: (2017)

Exploring a Tetrahydroquinoline Antimalarial Hit from the Medicines for Malaria Pathogen Box and Identification of its Mode of Resistance as PfeEF2
por: Laleu, Benoît, et al.
Publicado: (2022)

Fueling Open Innovation for Malaria Transmission-Blocking Drugs: Hundreds of Molecules Targeting Early Parasite Mosquito Stages
por: Delves, Michael, et al.
Publicado: (2019)

The Activities of Current Antimalarial Drugs on the Life Cycle Stages of Plasmodium: A Comparative Study with Human and Rodent Parasites
por: Delves, Michael, et al.
Publicado: (2012)

Identification of a κ-opioid agonist as a potent and selective lead for drug development against human African trypanosomiasis
por: Jones, Deuan C., et al.
Publicado: (2010)

A novel multiple-stage antimalarial agent that inhibits protein synthesis
por: Baragaña, Beatriz, et al.
Publicado: (2015)

Discovery of a Novel Class of Orally Active Trypanocidal N-Myristoyltransferase Inhibitors
por: Brand, Stephen, et al.
Publicado: (2011)

Discovery of Inhibitors of Trypanosoma brucei by Phenotypic Screening of a Focused Protein Kinase Library
por: Woodland, Andrew, et al.
Publicado: (2015)

Optimisation of the Anti-Trypanosoma brucei Activity of the Opioid Agonist U50488
por: Smith, Victoria C, et al.
Publicado: (2011)

Lead Optimization of a Pyrazole Sulfonamide Series of Trypanosoma bruceiN-Myristoyltransferase Inhibitors: Identification and Evaluation of CNS Penetrant Compounds as Potential Treatments for Stage 2 Human African Trypanosomiasis
por: Brand, Stephen, et al.
Publicado: (2014)

The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis
por: Patterson, Stephen, et al.
Publicado: (2016)

A high throughput screen for next-generation leads targeting malaria parasite transmission
por: Delves, Michael J., et al.
Publicado: (2018)

A semi-automated method for counting fluorescent malaria oocysts increases the throughput of transmission blocking studies
por: Delves, Michael J, et al.
Publicado: (2010)

Open Source Drug Discovery: Highly Potent Antimalarial Compounds Derived from the Tres Cantos Arylpyrroles
por: Williamson, Alice E., et al.
Publicado: (2016)

Targeting the parasite in the mosquito: rationale and practicality
por: Sinden, Robert E, et al.
Publicado: (2012)

Quinol derivatives as potential trypanocidal agents
por: Capes, Amy, et al.
Publicado: (2012)

The R Enantiomer of the Antitubercular Drug PA-824 as a Potential Oral Treatment for Visceral Leishmaniasis
por: Patterson, Stephen, et al.
Publicado: (2013)

Discovery of Indoline-2-carboxamide Derivatives as a New Class of Brain-Penetrant Inhibitors of Trypanosoma brucei
por: Cleghorn, Laura A. T., et al.
Publicado: (2015)

Development and validation of a cytochrome c-coupled assay for pteridine reductase 1 and dihydrofolate reductase
por: Shanks, Emma J., et al.
Publicado: (2010)

Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis
por: Baragaña, Beatriz, et al.
Publicado: (2019)

Development of Small-Molecule Trypanosoma brucei N-Myristoyltransferase Inhibitors: Discovery and Optimisation of a Novel Binding Mode
por: Spinks, Daniel, et al.
Publicado: (2015)

Cyclization-blocked proguanil as a strategy to improve the antimalarial activity of atovaquone
por: Skinner-Adams, Tina S., et al.
Publicado: (2019)

A role for trypanosomatid aldo-keto reductases in methylglyoxal, prostaglandin and isoprostane metabolism
por: Roberts, Adam J., et al.
Publicado: (2018)

A Molecular Hybridization Approach for the Design of Potent, Highly Selective, and Brain-Penetrant N-Myristoyltransferase Inhibitors
por: Harrison, Justin R., et al.
Publicado: (2018)

High-Throughput Luciferase-Based Assay for the Discovery of Therapeutics That Prevent Malaria
por: Swann, Justine, et al.
Publicado: (2016)

Synthesis and Bioactivity of Phthalimide Analogs as Potential Drugs to Treat Schistosomiasis, a Neglected Disease of Poverty
por: Singh, Snigdha, et al.
Publicado: (2020)

Synthesis and Evaluation of 1-(1-(Benzo[b]thiophen-2-yl)cyclohexyl)piperidine (BTCP) Analogues as Inhibitors of Trypanothione Reductase
por: Patterson, Stephen, et al.
Publicado: (2009)

P. falciparum In Vitro Killing Rates Allow to Discriminate between Different Antimalarial Mode-of-Action
por: Sanz, Laura M., et al.
Publicado: (2012)

Hundreds of dual-stage antimalarial molecules discovered by a functional gametocyte screen
por: Miguel-Blanco, Celia, et al.
Publicado: (2017)

Screening and hit evaluation of a chemical library against blood-stage Plasmodium falciparum
por: Avery, Vicky M, et al.
Publicado: (2014)

Probing the Open Global Health Chemical Diversity Library for Multistage-Active Starting Points for Next-Generation Antimalarials
por: Abraham, Matthew, et al.
Publicado: (2020)

An essential role of the basal body protein SAS-6 in Plasmodium male gamete development and malaria transmission
por: Marques, Sara R, et al.
Publicado: (2015)

Design, Synthesis and Biological Evaluation of Trypanosoma brucei Trypanothione Synthetase Inhibitors
por: Spinks, Daniel, et al.
Publicado: (2012)

Prioritization of Molecular Targets for Antimalarial Drug Discovery
por: Forte, Barbara, et al.
Publicado: (2021)

Dihydroquinazolines as a Novel Class of Trypanosoma brucei Trypanothione Reductase Inhibitors: Discovery, Synthesis, and Characterization of their Binding Mode by Protein Crystallography
por: Patterson, Stephen, et al.
Publicado: (2011)

Development of a 2,4-Diaminothiazole Series for the Treatment of Human African Trypanosomiasis Highlights the Importance of Static–Cidal Screening of Analogues
por: Cleghorn, Laura A. T., et al.
Publicado: (2023)

Investigation of Trypanothione Reductase as a Drug Target in Trypanosoma brucei
por: Spinks, Daniel, et al.
Publicado: (2009)

Activation of Bicyclic Nitro-drugs by a Novel Nitroreductase (NTR2) in Leishmania
por: Wyllie, Susan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_re876a8assumpee57ts0m1c0lc